Gavin Teo
General Partner @ Altara Ventures
San Francisco, United States
Gavin Teo is a Series A investor at Altara Ventures in San Francisco focused on Health Care and Artificial Intelligence. Gavin Teo is based out of Singapore, Central Region and is the General Partner of Altara Ventures. Gavin previously worked at Med247 as a Board Member. Gavin Teo attended the Wharton School of the University of Pennsylvania.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 88%
Last updated:
For AI agents: llms.txt
Industries Gavin Teo invests in
Stages Gavin Teo invests in
Countries Gavin Teo invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (63%)
- Artificial Intelligence 4 (50%)
- Medical 2 (25%)
- Software 2 (25%)
- Wellness 2 (25%)
Stage
- Series A 4 (50%)
- Series B 2 (25%)
- Seed 1 (13%)
- Series C 1 (13%)
Country
- United States 4 (50%)
- Sweden 1 (13%)
- Hungary 1 (13%)
- Indonesia 1 (13%)
- Singapore 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Klinik Pintar
|
IDI Smart Clinic is a digital clinic network in collaboration with Smart Clinic and PB IDI. Klinik Pintar is a health tech that serves as an operational partner for clinics in optimizing services to patients. | $5M / Series A / Dec 11, 2023 | |
KYAN Therapeutics
|
KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncologyand infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN's clinically-validated platforms are uniquely disease-mechanism and indication agnostic. | $5M / Seed / Oct 26, 2022 | |
Fishbrain
|
Fishbrain is a mobile app, commerce platform, and social network for people who love fishing. This free-to-use app provides tools, insights, support, and fishing gear to fully enjoy fishing. It also has an interactive map that helps anglers find new fishing spots and see what other people are catching, with what bait, and specifically where. | $13.5M / Series B / Mar 07, 2018 | |
Numerion Labs
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any otherAI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn. | $45M / Series A / Mar 07, 2018 | |
AImotive
|
Developing self-driving software, proprietary simulation tools and neural network acceleration hardware IP, AImotive is building an ecosystem to aid the deployment of automated driving. To catalyse industry collaboration our products are scalable, modular and hardware agnostic. We build on our team’s expertise in artificial intelligence, sensorfusion, 3D graphics and real-world automated driving workloads, to support partners in realizing their self-driving goals. | $38M / Series C / Jan 04, 2018 | |
Bright.md
|
Bright.md is a developer of an AI-powered virtual-care platform designed to modernize direct-to-patient telehealth for healthcare systems. The company partners with premier healthcare organizations to offer SmartExam to more than 10 million patients who are seeking convenient urgent and primary care online, connecting them to their physicians via ahome computer or mobile device reducing visits, enabling patients to receive conveniently, high quality, asynchronous, online care from established and trusted health system providers.The company was founded in 2014 and is based in Portland, Oregon. | $8M / Series B / Jul 17, 2017 | |
SilverCloud Health
|
SilverCloud Health provides immediate access to evidence-based and supported digital therapies. SilverCloud’s engagement has shown a three-fold increase in client/patient engagement and a three-fold decrease in client/patient program dropout when compared with current leading online therapeutic products. It was founded in 2011 andheadquartered in Boston, Massachusetts. | $8.1M / Series A / Jan 18, 2017 | |
Baobab Studios
|
Baobab Studios, headquartered in Redwood City, Calif., is a virtual reality company that creates story and character-driven cinematic experiences. The company was founded by Maureen Fan, who was most recently VP of Games at Zynga; and Eric Darnell, the director of such DreamWorks animated features as the four "Madagascar” franchise films and“Antz.” Baobab is funded by Comcast Ventures, HTC, Samsung, Advancit Capital, The Chernin Group and Freelands Ventures, along with individuals including Zynga co-founder Mark Pincus and PayPal co-founder Peter Thiel. | $6M / Series A / Dec 03, 2015 |
Co-Investors
About Altara Ventures
Altara Ventures aims to invest in the fintech, consumer, enterprise software, logistics, healthcare and edutech verticals.
Altara Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dave Ng
General Partner
|
|||
|
Gavin Teo
General Partner
|
|||
Huiting Koh
Partner & CMO
|
|||
Seow Kiat Wang
Co-Founder & General /Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gavin Teo invest in?
Gavin Teo invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gavin Teo?
Public channels for Gavin Teo include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gavin Teo last invest?
The most recent investment recorded for Gavin Teo closed in Dec 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
